National Association of Pharmacy Regulatory Authorities
National Association of Pharmacy Regulatory Authorities

Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Reset
Print Friendly Export to CSV
Drug Name Comment Schedule Date
Dabigatran or its salts or derivativesPDL

including but not limited to dabigatran etexilate

 I DEC / 13
Dabrafenib or its saltsPDL I DEC / 13
DacarbazinePDL I DEC / 13
Daclatasvir or its saltsPDL I OCT / 15
DaclizumabPDL I DEC / 13
Daclizumab betaPDL I FEB / 17
Dacomitinib or its saltsPDL I MAR / 19
DactinomycinPDL I DEC / 13
Dalbavancin or its saltsPDL I OCT / 18
Dalfopristin or its saltsPDL I DEC / 13
Dalteparin or its saltsPDL I DEC / 13
Danaparoid or its salts or derivativesPDL I DEC / 13
DanazolPDL I DEC / 13
Danofloxacin or its saltsPDL I DEC / 13
Danthron III SEP / 98
Dantrolene or its saltsPDL I DEC / 13
Dapagliflozin or its derivativesPDL I MAR / 15
Dapiprazole or its saltsPDL I DEC / 13
DaptomycinPDL I DEC / 13
DaratumumabPDL I AUG / 16
Darifenacin or its saltsPDL I DEC / 13
DarolutamidePDL I JUL / 20
DarunavirPDL I DEC / 13
Dasabuvir or its saltsPDL I MAR / 15
DasatanibPDL I DEC / 13
Daunorubicin or its saltsPDL I DEC / 13
Debrisoquin or its saltsPDL I DEC / 13
Decitabine or its saltsPDL I FEB / 19
DeferasiroxPDL I DEC / 13
Deferiprone or its derivativesPDL I MAR / 15
Deferoxamine or its saltsPDL I DEC / 13
Defibrotide or its salts or derivativesPDL I SEP / 17
Degarelix or its salts or derivativesPDL I DEC / 13
Dehydrocholic acid and its salts III SEP / 98
Delavirdine or its saltsPDL I DEC / 13
DenosumabPDL I DEC / 13
Deoxycholic acid or its saltsPDL

when used in an injectable form

 I OCT / 15
Dequalinium chloridePDL

when sold for the treatment of bacterial vaginosis

 I NOV / 21
DeracoxibPDL I DEC / 13
Derquantel or its saltsPDL

for veterinary use

 I AUG / 16
Deserpidine or its alkaloids or saltsPDL I DEC / 13
DesfluranePDL I DEC / 13
Desipramine or its saltsPDL I DEC / 13
Desloratadine and its salts and preparations.

in products marketed for adult use - 12 years and older

 U SEP / 05
Desloratadine and its salts and preparations. in products marketed for paediatric use - under 12 years of age III SEP / 05
Desmopressin or its saltsPDL I DEC / 13
Desoxyribonuclease [pancreatic dornase] II SEP / 98
Desvenlafaxine or its saltsPDL

including but not limited to desvenlafaxine succinate

 I DEC / 13
Detomidine or its saltsPDL I DEC / 13
Dexbrompheniramine and its salts III SEP / 98
Dexchlorpheniramine and its salts III SEP / 98
Dexrazoxane or its saltsPDL I DEC / 13
Dextromethorphan and its salts except in oral dosage forms in package sizes containing no more than 300mg DM base or 409.3 DM hydrobromide III AUG / 02
Dextromethorphan and its salts. in oral dosage forms in package sizes containing no more than 300 mg DM base or 409.3 DM hydrobromide U AUG / 02
Dextrose

in injectable form, when used as a sclerosing agent

 II SEP / 98
Dextrose injection concentrated solutions for parenteral injection I JAN / 03
Diazoxide or its saltsPDL I DEC / 13
Dibotermin alfaPDL

for veterinary use

 I FEB / 14
Dichloroacetic acidPDL I DEC / 13
Diclofenac diethylamine

For human use - when sold as a single medicinal ingredient for topical use on the skin in concentrations greater than 1.16% and less than or equal to 2.32% for not more than 7 days - in package sizes containing greater than 2.6g of diclofenac diethylamine

 III JUL / 22
Diclofenac diethylamine.

For human use - when sold as a single medicinal ingredient for topical use on the skin in concentrations greater than 1.16% and less than or equal to 2.32% for not more than 7 days - in package sizes containing no more than 2.6g of diclofenac diethylamine

 U JUL / 22
Diclofenac diethylamine..

For human use - when sold as a single medicinal ingredient for topical use on the skin in concentrations of not more than 1.16% for not more than 7 days

 U JUL / 22
Diclofenac or its salts

For human use - including (but not limited to): diclofenac diethylamine, diclofenac sodium, diclofenac potassium, except diclofenac diethylamine when sold as a single medicinal ingredient for topical use on the skin in concentrations less than or equal to 2.32% for not more than 7 days

 I JUL / 22
Diclofenac or its saltsPDL

For veterinary use – including (but not limited to): diclofenac sodium, diclofenac potassium

 I AUG / 14
Dicyclomine and its salts except for topical use and lozenges II SEP / 98
Didanosine or its salts or derivativesPDL I DEC / 13
DiethylbromacetamidePDL I DEC / 13
Diethylcarbamazine or its saltsPDL I DEC / 13
Diethylpropion and any salt thereofC I JUN / 02
Diethylstilbestrol or its salts or derivativesPDL I DEC / 13
Difloxacin or its salts or derivativesPDL I DEC / 13
Diflunisal or its saltsPDL I DEC / 13
Digitalis lanata or its glycosides PDL I DEC / 13
Digitalis purpurea or its glycosides PDL I DEC / 13
Digoxin immune FabPDL

ovine

 I DEC / 13
Dihydroquinidine and its salts except phenylbarbiturate II SEP / 98
Dihydrostreptomycin or its salts or derivativesPDL

For human use

 I DEC / 18
DihydrotachysterolPDL

for human use

 I DEC / 13
DiiodohydroxyquinPDL

except in preparations for topical use on the skin

 I DEC / 13
Diiodohydroxyquin

for topical use on the skin

 II SEP / 98
Diltiazem or its saltsPDL I DEC / 13
Dimenhydrinate and its salts for parenteral use II SEP / 98
Dimenhydrinate and its salts. for oral or rectal use [Note: Pharmacists are advised that in areas where there is evidence of abuse or particular concern about abuse, dimenhydrinate products should not be located in a self-selection area of the pharmacy]. III APR / 99
DimercaprolPDL I DEC / 13
Dimethothiazine III SEP / 98
Dimethyl sulfoxidePDL

For veterinary use

 I DEC / 13
Dimethyl sulfoxidePDL

For human use, when sold for the treatment of interstitial cystitis or scleroderma

 I DEC / 13
DimethylfumaratePDL I DEC / 13
Dimeticone 100 cSt solution 50% w/w for topical use in the treatment of head lice III JAN / 13
2,4- Dinitrophenol or its salts or derivativesPDL I DEC / 13
DinutuximabPDL I DEC / 18
Diperodon and its salts except for topical use II SEP / 98
Diphenhydramine and its salts and preparations for parenteral use II SEP / 98
Diphenhydramine and its salts and preparations. except for parenteral or topical use III SEP / 98
Diphenhydramine and its salts and preparations.. for topical use in concentrations of greater than 2% II MAY / 06
Diphenhydramine and its salts and preparations... for topical use in concentrations of 2% or less when sold in containers of greater than 300 mg of diphenhydramine hydrochloride III MAY / 06
Diphenhydramine and its salts and preparations... for topical use in concentrations of 2% or less when sold in containers of 300 mg or less of diphenhydramine hydrochloride U OCT / 09
Diphenidol or its saltsPDL I DEC / 13
Diphenylhydantoin (phenytoin) or its saltsPDL I SEP / 98
Diphenylpyraline III SEP / 98
Diphtheria toxoid II DEC / 98
Dipivefrin or its saltsPDL I DEC / 13
Diprophylline or its saltsPDL I DEC / 13
DipyridamolePDL I DEC / 13
DirithromycinPDL

For human use

 I DEC / 13
DirlotapidePDL I DEC / 13
Disopyramide or its saltsPDL I DEC / 13
DisulfiramPDL I DEC / 13
Dithranol Anthralin II SEP / 98
Dobutamine or its saltsPDL I DEC / 13
Docetaxel or its derivativesPDL

including but not limited to cabazitaxel

 I DEC / 13
Docusate and its salts U
Dolasetron or its saltsPDL I DEC / 13
Dolutegravir or its saltsPDL I DEC / 13
DomperidonePDL I DEC / 13
Donepezil or its saltsPDL I DEC / 13
Dopamine or its saltsPDL

when sold for administration by injection

 I DEC / 13
DoravirinePDL I NOV / 18
Dornase alfaPDL I DEC / 13
Dorzolamide or its saltsPDL I DEC / 13
DostarlimabPDL I JAN / 22
Doxacurium chloridePDL I DEC / 13
DoxapramPDL I DEC / 13
Doxazosin or its saltsPDL I DEC / 13
Doxepin or its saltsPDL I DEC / 13
Doxercalciferol or its derivativesPDL I DEC / 13
Doxorubicin or its saltsPDL I DEC / 13
Doxycycline or its salts or derivativesPDL

including but not limited to doxycycline hyclate, doxycycline monohydrate

 I DEC / 13
Doxylamine or its salts

except those sold for nausea and vomiting of pregnancy

 III SEP / 98
Doxylamine or its saltsPDL

when sold or recommended for use in the nausea or vomiting of pregnancy

 I DEC / 13
Droperidol or its saltsPDL I DEC / 13
DrotrecoginPDL I DEC / 13
DulaglutidePDL I JAN / 16
Duloxetine or its saltsPDL I DEC / 13
DupilumabPDL I MAR / 18
DurvalumabPDL I DEC / 17
DutasteridePDL I DEC / 13
Dyclonine except for topical use on mucous membranes II SEP / 98
Dyclonine and its salts for topical use on mucous membranes, except lozenges III SEP / 98

139 result(s)

Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act